4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-008659
CEO sold 14,195 shares at $50.61 ($718,409)
- CEO acquired 31,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2021-02-04 | Grant or award | +31,250 | 43,059 | D | ||
| DAVIS STEPHEN CEO | 2021-02-04 | Sale | −14,195 | $50.61 | $718,409 | 28,900 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2021-02-04 | Grant or award · Employee Stock Options (Right to Buy) | +40,625 | 40,625 | D | ||
| DAVIS STEPHEN CEO | 2021-02-04 | Grant or award · Employee Stock Options (Right to Buy) | +40,625 | 40,625 | D | ||
| DAVIS STEPHEN CEO | 2021-02-04 | Grant or award · Employee Stock Options (Right to Buy) | +23,750 | 23,750 | D | ||
| Open-market sales · 14,195 sh · avg $50.61 · $718,409 | |||||||
Loading xslF345X03/doc4.xml…